 The landmark report of the diabetes control and complications trial DCCT trial has shown that intensive management delays andor prevents complications in small vessels associated with Type 1 diabetes T1DM. To achieve the goals of the DCCT, a number of new insulin analogs man-made insulins are now being incorporated into the management of patients with T1DM. 